5-(Pyridin-4-yl)isoxazol-3-ol
97%
- Product Code: 226788
CAS:
167414-97-3
| Molecular Weight: | 162.15 g./mol | Molecular Formula: | C₈H₆N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD03086353 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports the development of selective inhibitors due to its ability to mimic purine motifs in ATP-binding sites. Also explored in the design of antimicrobial and antiviral agents owing to its bioisosteric properties. Commonly employed in medicinal chemistry for scaffold modification to enhance potency, solubility, and metabolic stability in drug candidates.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | $928.85 |
+
-
|
5-(Pyridin-4-yl)isoxazol-3-ol
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports the development of selective inhibitors due to its ability to mimic purine motifs in ATP-binding sites. Also explored in the design of antimicrobial and antiviral agents owing to its bioisosteric properties. Commonly employed in medicinal chemistry for scaffold modification to enhance potency, solubility, and metabolic stability in drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :